[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$fbVHe1vrifFiWefHb1cMoquNKWeQW8p7cXPYC28RwXnc":3},{"sponsor":4,"sponsorVariants":5,"totalTrials":6,"truncated":7,"activeTrials":8,"phase3Count":9,"totalEnrollment":10,"activePrograms":11,"nonDrugCount":12,"topConditions":13,"upcomingReadouts":33,"phaseBuckets":39,"rows":46},"Scripps Translational Science Institute",[4],51,false,18,0,572369,1,47,[14,17,20,22,24,27,29,31],{"name":15,"count":16},"Coronary Artery Disease",4,{"name":18,"count":19},"Hypertension",3,{"name":21,"count":19},"Healthy",{"name":23,"count":19},"Cancer",{"name":25,"count":26},"Blood Pressure",2,{"name":28,"count":26},"Heart Failure",{"name":30,"count":26},"Prostate Cancer",{"name":32,"count":26},"Atrial Fibrillation",[34],{"nctId":35,"briefTitle":36,"date":37,"intervention":38},"NCT07128082","The Long COVID Treatment Trial","2026-12","Tirzepatide",[40,41,42,43,44,45],"EARLY_PHASE1","PHASE1","PHASE2","PHASE3","PHASE4","NA",[47,69,97,124,151],{"intervention":38,"totalTrials":11,"cells":48},{"EARLY_PHASE1":49,"PHASE1":51,"PHASE2":53,"PHASE3":63,"PHASE4":65,"NA":67},{"trials":50,"activeCount":9},[],{"trials":52,"activeCount":9},[],{"trials":54,"activeCount":11,"soonestReadout":37},[55],{"nctId":35,"briefTitle":36,"status":56,"phases":57,"primaryCompletion":37,"completion":37,"start":58,"enrollment":59,"conditions":60,"interventions":62},"ACTIVE_NOT_RECRUITING",[42],"2025-10-30",1000,[61],"Long COVID",[38],{"trials":64,"activeCount":9},[],{"trials":66,"activeCount":9},[],{"trials":68,"activeCount":9},[],{"intervention":70,"totalTrials":11,"cells":71},"Colchicine",{"EARLY_PHASE1":72,"PHASE1":87,"PHASE2":89,"PHASE3":91,"PHASE4":93,"NA":95},{"trials":73,"activeCount":9},[74],{"nctId":75,"briefTitle":76,"status":77,"phases":78,"primaryCompletion":79,"completion":79,"start":80,"enrollment":81,"conditions":82,"interventions":86},"NCT02083510","Apolipoprotein CIII Reduction Via Colchicine","COMPLETED",[40],"2014-05","2014-02",5,[83,84,85],"Hypertriglyceridemia","Gout","Pericarditis",[70],{"trials":88,"activeCount":9},[],{"trials":90,"activeCount":9},[],{"trials":92,"activeCount":9},[],{"trials":94,"activeCount":9},[],{"trials":96,"activeCount":9},[],{"intervention":98,"totalTrials":11,"cells":99},"Non intervention-Genetic testing",{"EARLY_PHASE1":100,"PHASE1":102,"PHASE2":104,"PHASE3":106,"PHASE4":108,"NA":110},{"trials":101,"activeCount":9},[],{"trials":103,"activeCount":9},[],{"trials":105,"activeCount":9},[],{"trials":107,"activeCount":9},[],{"trials":109,"activeCount":9},[],{"trials":111,"activeCount":9},[112],{"nctId":113,"briefTitle":114,"status":77,"phases":115,"primaryCompletion":116,"completion":117,"start":118,"enrollment":119,"conditions":120,"interventions":123},"NCT02668835","GADGET-PD Genetic and Digital Diagnosis of Essential Tremor and Parkinson's Disease Trial",[],"2017-02","2019-04","2015-11",67,[121,122],"Parkinson Disease","Essential Tremor",[98],{"intervention":125,"totalTrials":11,"cells":126},"Lisinopril",{"EARLY_PHASE1":127,"PHASE1":129,"PHASE2":131,"PHASE3":133,"PHASE4":135,"NA":137},{"trials":128,"activeCount":9},[],{"trials":130,"activeCount":9},[],{"trials":132,"activeCount":9},[],{"trials":134,"activeCount":9},[],{"trials":136,"activeCount":9},[],{"trials":138,"activeCount":9},[139],{"nctId":140,"briefTitle":141,"status":77,"phases":142,"primaryCompletion":143,"completion":143,"start":144,"enrollment":26,"conditions":145,"interventions":149},"NCT01258764","Hypertensive Ambulatory Trial to Compare the Efficacy of HCTZ and Lisinopril",[45],"2014-03","2010-11",[146,147,148,18],"Hypertension, Grade 1","Hypertension Treatment","N of 1 Study Design",[125,150],"Hydrochlorothiazide",{"intervention":150,"totalTrials":11,"cells":152},{"EARLY_PHASE1":153,"PHASE1":155,"PHASE2":157,"PHASE3":159,"PHASE4":161,"NA":163},{"trials":154,"activeCount":9},[],{"trials":156,"activeCount":9},[],{"trials":158,"activeCount":9},[],{"trials":160,"activeCount":9},[],{"trials":162,"activeCount":9},[],{"trials":164,"activeCount":9},[165],{"nctId":140,"briefTitle":141,"status":77,"phases":166,"primaryCompletion":143,"completion":143,"start":144,"enrollment":26,"conditions":167,"interventions":168},[45],[146,147,148,18],[125,150]]